ALB and urinary bladder carcinoma: A study by Lin et al. [78] developed an O2 self-sufficient active nanobioconjugate consisting of human serum albumin (HSA), MnO2, and Ce6 (HSA-MnO2-Ce6 NPs) to alleviate tumor hypoxia and thus enhance PDT treatment of bladder cancer.